Axogen, Inc. — Director's Dealing 2021

Nov 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2021-11-24

Reporting Person: Zaderej Karen L. (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-24	Common Stock	M	52375	$8.95	Acquired	921147	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-24	Employee Stock Option (right to purchase)	$8.95	M	52375	Disposed	2026-12-29	Common Stock (52375.0)	Direct

Footnotes

F1: The Reporting Person has elected to exercise and hold the shares at this time.

F2: All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.